Prof. Maoyi Xu | Thoracic Neoplasms | Best Researcher Award

Published on 02/01/202502/01/2025 by Oncology

Prof. Maoyi Xu | Thoracic Neoplasms | Best Researcher Award

The Affiliated Hospital of Jiaxing University | China

AUTHOR PROFILE

🏫 EARLY ACADEMIC PURSUITS

Maoyi Xu began his academic journey with a Bachelor of Medicine in Clinical Medicine at Jiaxing University (2009–2014). During these formative years, Xu developed a strong foundation in medical sciences and clinical applications, showcasing a keen interest in oncology. This passion led him to pursue advanced education, obtaining a Master of Medicine in Oncology from Dalian Medical University, China, in 2017. His graduate studies were characterized by rigorous research and hands-on training, laying the groundwork for his future career in oncology.

💼 PROFESSIONAL ENDEAVORS

Maoyi Xu’s professional career began with a pivotal role at the Department of Radiotherapy Oncology, Zhuji People’s Hospital of Zhejiang Province (2017–2019), affiliated with Wenzhou Medical University. Here, he honed his skills in radiotherapy and gained invaluable experience treating cancer patients.
In 2019, Xu transitioned to the Department of Oncology at the First Affiliated Hospital of Jiaxing University, where he continues to work. His role involves comprehensive patient care, cutting-edge research, and contributions to the hospital’s oncology department’s growth.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON THORACIC NEOPLASMS

Xu has focused his research on innovative cancer treatment strategies, particularly in radiotherapy and targeted oncology treatments. He is committed to improving patient outcomes by integrating the latest advancements in oncology into clinical practice. Xu’s research bridges the gap between theory and application, enhancing therapeutic methodologies to benefit patients.

🌟 IMPACT AND INFLUENCE

Through his work, Xu has positively influenced oncology practices within Zhejiang Province and beyond. His contributions have led to advancements in radiotherapy techniques and improved patient care protocols. Xu is also a mentor to young professionals, fostering a culture of learning and collaboration.

📊 ACADEMIC CITATIONS

Although Xu’s academic citations are in development, his publications have started to gain recognition in medical circles. His research papers focus on innovative radiotherapy approaches and patient-centered care strategies. These contributions are adding value to the field of oncology.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Maoyi Xu is poised to leave a lasting legacy as a dedicated oncologist and researcher. He envisions a future where his contributions will significantly impact cancer treatment practices and policies, particularly in China. Xu aims to pioneer new research initiatives, foster interdisciplinary collaboration, and improve cancer care at both the local and global levels.

📝 CONCLUSION

Maoyi Xu’s journey from an aspiring medical student to a dedicated oncologist and researcher exemplifies a commitment to excellence and innovation in the field of oncology. His academic pursuits laid a solid foundation for his professional growth, while his clinical and research contributions continue to impact cancer treatment and patient care.

📊🔬NOTABLE PUBLICATION:

The combination of decitabine and aspirin inhibits tumor growth and metastasis in non-small cell lung cancer
- Authors: Xu, M., Song, B., Yang, X., Li, N.
- Journal: Journal of International Medical Research
- Year: 2022

Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway
- Authors: Song, B., Hou, G., Xu, M., Chen, M.
- Journal: Cellular Signalling
- Year: 2024

Zoledronic acid inhibits the bone metastasis of breast cancer by repressing exosome-loaded DKK1
- Authors: Song, B.B., Xu, M.Y., Xu, X.F., Li, X., Chen, M.
- Journal: Bangladesh Journal of Pharmacology
- Year: 2022

Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
- Authors: Zhang, Y.-F., Wang, G.-D., Huang, M.-G., Si, J., Xu, M.-Y.
- Journal: World Journal of Gastrointestinal Oncology
- Year: 2023

β-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-κB/HIF-1α signaling pathway
- Authors: Yu, X., Li, Z., Zhang, Y., Zou, K., Zou, L.
- Journal: OncoTargets and Therapy
- Year: 2019

Mr. Ji Huang | Dosimetric Research | Best Researcher Award

Published on 31/12/202431/12/2024 by Oncology

Mr. Ji Huang | Dosimetric Research | Best Researcher Award

National Institute of Metrology | China

Author Profile

Scopus

🌟 Biography of Huang Ji 🌟

🧪 Full Name:

Huang Ji

🏛️ Designation:

Research Professor

🏢 Institution/Organization:

National Institute of Metrology, China (NIM)

🌐 Academic and Professional Background

Huang Ji is a distinguished researcher in ionizing radiation metrology with a focus on FLASH radiotherapy, small-field dosimetry standards, and metrology systems. He has contributed to the establishment of two national standards and drafted two technical specifications in radiotherapy metrology. Huang serves as the Deputy Secretary-General of the Ionizing Radiation Committee of the China Society for Measurement and is an active member of the Medical Physics Division of the Chinese Nuclear Society.

🔬 Research and Innovations

🎯 Completed/Ongoing Research Projects: Led several national-level projects, including the Young Scientists Program of the National Key R&D Program and projects funded by the National Natural Science Foundation of China.
📈 Citation Index: H-Index of 11.
🔗 Consultancy/Industry Projects: Worked on projects under the National Key R&D Program and National Natural Science Foundation of China.
📚 Books Published (ISBN): None.
🔒 Patents Published/Under Process: Over 10 invention patents.
📝 Journals Published: More than 20 SCI-indexed papers.
🖋️ Editorial Appointments: Editorial member of Nuclear Science and Technology.

🤝 Collaborations

Worked with prominent institutions such as:

Tsinghua University
Beijing Cancer Hospital
Peking University
China Academy of Engineering Physics

🌟 Professional Memberships

Deputy Secretary-General, Ionizing Radiation Committee, China Society for Measurement
Member, Medical Physics Division, Chinese Nuclear Society

🔍 Areas of Research

Huang Ji’s research focuses on:

FLASH radiotherapy
Small-field dosimetry standards
Advanced metrology systems

🚀 Key Contributions

Huang Ji developed a comprehensive Monte Carlo model to analyze dosimetry errors and introduced an innovative FFF output correction factor. This breakthrough addresses dosimetry errors across various ionization chambers and electron angle conditions, significantly advancing precision in FFF radiotherapy.

🌟 Impact: His work enhances accuracy in radiotherapy, contributing to improved patient outcomes and advancing metrology science.

📊🔬NOTABLE PUBLICATION:

Uniformity Control of Laser-Induced Periodic Surface Structures
- Authors: Huang, J.; Liu, Y.; Jin, S.; Wang, K.; Qiu, R.
- Journal: Frontiers in Physics
- Year: 2022

Single-Pixel-Adjustable Structural Color Fabricated Using a Spatially Modulated Femtosecond Laser
- Authors: Liu, Y.; Jiang, L.; Li, X.; Ye, Y.; Wang, Z.
- Journal: ACS Applied Materials and Interfaces
- Year: 2023

Efficient Fabrication of Infrared Antireflective Microstructures on a Curved Diamond-ZnS Composite Surface by Using Femtosecond Bessel-like Beams
- Authors: Mengnan, W.U.; Jiang, L.; Taoyong, L.I.; Zhang, X.; Li, X.
- Journal: Optics Express
- Year: 2023

Development and Application of Absorbed Dose Primary Standard for $^{60}$ Co and High-Energy Photon Beams Using Water Calorimetry
- Authors: Wang, Z.; Wang, K.; Jin, S.; Qi, Y.; Zhang, J.
- Journal: Metrologia
- Year: 2023

Alternate Morphology Evolution of Bulge Structures on Thin Gold Films Induced by Internal Stress Distribution Adjusted by Femtosecond Laser Double-Pulse
- Authors: Gao, S.; Li, X.; Lian, Y.; Fu, Z.; Huang, J.
- Journal: Optics and Laser Technology
- Year: 2022

Prof. Xinyan Zhao | Liver Injury | Best Researcher Award

Published on 31/12/202408/01/2025 by Oncology

Prof. Xinyan Zhao | Liver Injury | Best Researcher Award

Beijing Friendship Hospital, Capital Medical University | China

Author Profile

Scopus

Google Scholar

Biography of Xin Yan Zhao, M.D., Ph.D. 🌟🩺

Professor of Medicine | Head of Liver Research Center | Expert in Hepatology

Dr. Xin Yan Zhao is a distinguished Professor of Medicine and the Head of the Liver Research Center at Beijing Friendship Hospital, Capital Medical University, Beijing, China. She is also affiliated with the National Clinical Research Center for Digestive Disease, where she leads groundbreaking research in hepatology and liver transplantation pathology.

🎓 Education

M.D. (1995–2000)
Clinical Medicine, Capital Medical University, Beijing, China
M.S. (2000–2003)
Internal Medicine, Capital Medical University, Beijing, China
Ph.D. (2005–2008)
Hepatology, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China

👩‍⚕️ Professional Experience

Head of Liver Research Center (2022–Present)
Beijing Friendship Hospital, Capital Medical University
Hepatologist & Clinical Liver Pathologist (2016–2022)
Beijing Friendship Hospital, Capital Medical University
Visiting Scholar (2015–2016)
Department of Liver and Transplant Pathology, University of Pittsburgh Medical Center, USA
Associate Professor (2014–2015)
Beijing Friendship Hospital, Capital Medical University
Attending Doctor, Department of Hepatology (2009–2014)
Beijing Friendship Hospital, Capital Medical University
Chief Resident of Internal Medicine (2008)
Beijing Friendship Hospital, Capital Medical University
Resident of Internal Medicine (2003–2007)
Beijing Friendship Hospital, Capital Medical University

🏆 Awards and Honors

2006: Excellent Paper Presentation Award, Chinese Society of Hepatology
2008, 2010, 2013: Excellence in Teaching Award, Beijing Friendship Hospital
2010: Award for Teaching Presentation and Skills in English, Capital Medical University
2014: Excellent Young Investigator Award, APASL College, Beijing
2018: Excellent Paper Presentation Award, Beijing Digestive Disease Weekend

🌐 Roles in Professional Societies

Chairman (2024–2025), Pathology Committee, International Liver Transplantation Society 🌍
Committee Member, Autoimmune Hepatitis Cooperation Group, Chinese Society of Hepatology
Committee Member, Transplantation Pathology, Chinese Medical Doctor Association
Committee Member, Digestive Pathology Cooperation Group, Chinese Society of Digestive Diseases

🌏 CONCLUSION

Dr. Xin Yan Zhao exemplifies excellence in medicine, research, and education. As a globally recognized leader in hepatology and liver transplantation pathology, she continues to drive innovation and collaboration in the field. Her dedication to advancing medical knowledge, training the next generation of physicians, and contributing to professional societies underscores her significant impact on liver research and clinical practice worldwide. 🌟🩺

📊🔬NOTABLE PUBLICATION:

Peridroplet mitochondria are associated with the severity of MASLD and the prevention of MASLD by diethyldithiocarbamate
- Authors: Sun, X.; Yu, Q.; Qi, Y.; Cong, M.; Liu, T.
- Journal: Journal of Lipid Research
- Year: 2024

Autoimmune hepatitis with confluent necrosis indicates severe liver injury but responds well to standard immunosuppressive therapy
- Authors: Sun, X.; Su, Y.; Wee, A.; Zhao, X.; Jia, J.
- Journal: Histology and Histopathology
- Year: 2024

Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval
- Authors: Xu, X.; Meng, T.; Shi, L.; Jia, J.; Kong, Y.
- Journal: Journal of Autoimmunity
- Year: 2024

Multiscale X-ray phase-contrast CT uncovers adaptive changes and compensatory mechanisms of circulatory pathways during acute liver injury
- Authors: Zhao, Y.; Lv, W.; He, Y.; Hu, C.; Jian, J.
- Journal: Communications Biology
- Year: 2024

Multiple Low-Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy
- Authors: Lu, Z.; Sun, Y.-M.; Chen, S.; Zhao, X.; You, H.
- Journal: Journal of Viral Hepatitis
- Year: 2024

Dr. Ohidul Alam | Oncology Case Reports | Best Researcher Award

Published on 30/12/202430/12/2024 by Oncology

Dr. Ohidul Alam | Oncology Case Reports | Best Researcher Award

Jiangsu University | China

Author Profile

Scopus

Google Scholar

🌍 Dr. Ohidul Alam: Postdoctoral Research Fellow and Environmental Innovator 🌱

💧Current Position

Postdoctoral Research Fellow, Institute of Environment and Ecology, School of the Environment and Safety Engineering, Jiangsu University

♻️Research Focus

Dr. Ohidul Alam is dedicated to advancing environmental sustainability and ecological safety. His primary research interests include:

🌊 Coastal Environment and Wetlands: Investigating microplastics as vectors for antibiotic resistance genes (ARGs) and heavy metals.
♻️ Hazardous Waste Management: Treatment and recycling of waste and heavy metals.
💧 Wastewater Treatment and Pollution Control: Developing advanced environmental materials like adsorbents and composites for energy storage and purification.
🧬 Antibiotic Resistance Genes: Exploring ARG mechanisms in ecological systems.

🎓Education

PhD in Environmental Engineering, East China University of Science and Technology, Shanghai, China (2016–2021)
MEng in Environmental Engineering, UNEP-Tongji Institute of Environment for Sustainable Development, Tongji University, Shanghai, China (2014–2016)
MS in Environmental Science, Institute of Forestry and Environmental Sciences, University of Chittagong, Bangladesh (2010–2011)

🛠Career Snapshot

Postdoctoral Research (2023–Present): Investigating microplastics as vehicles for ARGs and toxic heavy metals in coastal wetlands, assessing ecological and health risks.
Environmental Officer (2022–2023): Sustainable Enterprise Project (SEP), Integrated Development Foundation (IDF).
Research Associate and Assistant: Contributed to seven major academic and socio-environmental projects.

🖋Publications and Contributions

Published 15 SCI-indexed journal papers, 9 international open-access journal articles, and 13 international conference papers.
Authored 3 national journal articles and 3 technical/working papers.
Supported colleagues in research, thesis writing, and scientific publications.

🏆Recognition and Awards

Chinese Scholarship Council (CSC) and Marine Scholarship of China (MSC), 2014
Tongji University President Scholarship (2nd Prize), 2015, for academic excellence.

🤝Professional Memberships

International Waste Working Group (IWWG)
Human Development Foundation (HDF)

🧾Reviewer Roles

Journal of Environmental Management
Environmental Research
Environment, Development and Sustainability
Water Science and Technology

📚Training and Skills Development

Completed advanced training on the Leaching Environmental Assessment Framework (LEAF) for waste treatment and beneficial reuse.

Dr. Alam’s interdisciplinary approach bridges the gap between environmental engineering, sustainable development, and ecological safety. His work continues to inspire progress toward a cleaner, safer world. 🌍✨

🌏 CONCLUSION

Dr. Ohidul Alam exemplifies dedication to environmental sustainability through his groundbreaking research on hazardous waste management, pollution control, and ecological risks posed by microplastics. His extensive academic achievements, impactful publications, and hands-on contributions to global environmental projects highlight his expertise and commitment to creating sustainable solutions for pressing environmental challenges. As a scholar, innovator, and mentor, Dr. Alam continues to pave the way for a cleaner, safer, and more sustainable future. 🌱🌍

📊🔬NOTABLE PUBLICATION:

Title: An in-depth review on municipal solid waste management, treatment, and disposal in Bangladesh
- Authors: Alam, O.; Qiao, X.
- Journal: Sustainable Cities and Society
- Year: 2020

Title: A preliminary life cycle assessment on healthcare waste management in Chittagong City, Bangladesh
- Authors: Alam, O.; Mosharraf, A.
- Journal: International Journal of Environmental Science and Technology
- Year: 2020

Title: Influences of chemically controlled Ca-bearing minerals in chitosan on Pb²⁺ removal efficiency
- Authors: Alam, O.; Qiao, X.
- Journal: Journal of Environmental Health Science and Engineering
- Year: 2020

Title: The effect of Ca-bearing contents in chitosan on Pb²⁺, Cd²⁺, and Cu²⁺ adsorption and its adsorption mechanism
- Authors: Alam, O.; Qiao, X.; Nath, T.K.
- Journal: Journal of Environmental Health Science and Engineering
- Year: 2020

Title: Remediation of heavy metals polluted soil environment: A critical review on biological approaches
- Authors: Zheng, X.; Lin, H.; Du, D.; Jiang, S.; Li, J.
- Journal: Ecotoxicology and Environmental Safety
- Year: 2024

Prof. Dehua Li | Peri-implantitis | Best Researcher Award

Published on 28/12/202428/12/2024 by Oncology

Prof. Dehua Li | Peri-implantitis | Best Researcher Award

Air Force Medical University | China

Author Profile

Scopus

🌟Biography of Dehua, Li 🦷🧬

Dr. Dehua Li is a researcher at the State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Air Force Medical University, Xi’an, China. His work bridges cutting-edge nanotechnology with transformative solutions in biomedicine, particularly for dental health applications.

🔬 Research Focus

Development and application of nanotechnology in biomedical fields
Innovative strategies for biofilm decontamination and peri-implantitis management in dental implantology
Design of pH-responsive drug delivery systems for precision medicine
Interdisciplinary approaches to integrating nanomaterial technologies into clinical solutions

💡 Key Contributions

Designed D-arginine-loaded pH-responsive mesoporous silica nanoparticles (Dar@MSN-COS) to target biofilms on dental implants effectively.
Spearheaded in vitro and in vivo studies demonstrating the biocompatibility and therapeutic potential of Dar@MSN-COS in treating peri-implantitis.
Advanced research into the synergistic effects of nanotechnology and mechanical decontamination techniques, such as water jet therapy, for improving implant reosseointegration.

🔧 Core Skills

Nanoparticle synthesis and functionalization
Advanced microscopy techniques, including SEM and CLSM
Expertise in drug release profiling, cytotoxicity assays, and biofilm characterization
Proficiency in analytical tools like FTIR, DLS, and statistical software (SPSS, GraphPad Prism)

🏆 Awards and Grants

Recipient of the Foundation of National Clinical Research Center for Oral Diseases (Grant NO: LCC202202)

With his innovative approaches and multidisciplinary expertise, Dr. Dehua Li is contributing to the advancement of precision medicine and oral health, fostering solutions that promise better outcomes in implantology and beyond.

🌏 CONCLUSION

In conclusion, Dr. Dehua Li is at the forefront of advancing dental health and precision medicine through his expertise in nanotechnology and biomaterials science. His innovative work in developing pH-responsive drug delivery systems and synergistic decontamination methods addresses critical challenges in peri-implantitis management and dental implantology.

📊🔬NOTABLE PUBLICATION:

Additive Manufacturing Technologies in the Oral Implant Clinic: A Review of Current Applications and Progress
- Authors: Huang, S., Wei, H., Li, D.
- Journal: Frontiers in Bioengineering and Biotechnology
- Year: 2023

Asperuloside Prevents Peri-Implantitis via Suppression of NF-κB and ERK1/2 on Rats
- Authors: Wang, X., Chen, X., Zhang, Z., Wei, H., Li, D.
- Journal: Pharmaceuticals
- Year: 2022

A Novel Technique for Implant-Supported Fixed Complete Rehabilitation Based on a Dynamic Virtual Patient
- Authors: Wang, J., Wu, Y.-L., Ma, J., Wu, F., Li, D.-H.
- Journal: Journal of Dentistry
- Year: 2023

Surgical Principles and the Decision-Making for Peri-Implant Keratinized Mucosa Augmentation
- Authors: Li, D.
- Journal: Chinese Journal of Stomatology
- Year: 2023

Influences of Standardized Clinical Probing on Peri-Implant Soft Tissue Seal in a Situation of Peri-Implant Mucositis: A Histomorphometric Study in Dogs
- Authors: Cai, R., Liu, Y., Wang, X., Lei, J., Li, D.
- Journal: Journal of Periodontology
- Year: 2024

Assoc. Prof. Dr. Shi-liang Huang | Tumor | Best Researcher Award

Published on 23/12/202423/12/2024 by Oncology

Assoc. Prof. Dr. Shi-liang Huang | Tumor | Best Researcher Award

Sun Yat-sen University | China

AUTHOR PROFILE

Scopus

ORCID ID

🧑‍🔬 DR. SHI-LIANG HUANG

Associate Professor in Medicinal Chemistry
Sun Yat-sen University, People’s Republic of China

🎯 OBJECTIVE

Dedicated Associate Professor specializing in Medicinal Chemistry, with a passion for driving innovation in drug discovery and development, focusing on the tumor microenvironment and the heat shock response.

📘 EARLY ACADEMIC PURSUITS

Dr. Huang’s academic journey began with a solid foundation in Chemistry and Biochemistry, laying the groundwork for a distinguished career. After excelling in undergraduate studies, Dr. Huang pursued advanced degrees in Medicinal Chemistry, demonstrating exceptional aptitude for research and innovation.

Key achievements during this phase include:

Master’s Thesis: Groundbreaking work on natural product derivatives for therapeutic applications.
Doctoral Research: Advanced studies on the mechanisms of small molecules in altering biochemical pathways.

🏢 PROFESSIONAL ENDEAVORS

As an Associate Professor at Sun Yat-sen University, Dr. Huang has significantly contributed to the university’s reputation as a leading institution in medicinal research. His professional journey is marked by:

Leading Interdisciplinary Teams: Collaborating with experts in oncology, biochemistry, and computational modeling.
Research Innovation: Pioneering techniques in synthesizing inhibitors targeting heat shock proteins (HSPs) and heat shock factor 1 (HSF1).
Teaching Excellence: Mentoring students in natural medicinal chemistry and drug design methodologies.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Huang’s work revolves around integrating bioorganic chemistry with tumor microenvironment studies to innovate cancer therapies. Key contributions include:

Medicinal Chemistry: Developing novel molecules with high specificity for cancer-related targets.
Natural Product Exploration: Isolating and modifying natural compounds to enhance their therapeutic potential.
Heat Shock Response Modulation: Designing inhibitors to disrupt HSF1 and HSP pathways, which are critical in cancer cell survival under stress.
Tumor Microenvironment Studies: Investigating how microenvironmental factors influence drug efficacy.

🌟 IMPACT AND INFLUENCE

Dr. Huang’s research has had a profound impact on the scientific community and beyond:

Published Works: Author of numerous peer-reviewed articles in high-impact journals.
Citations and Recognition: Garnered widespread academic citations, reflecting the influence and applicability of his research.
Collaboration and Leadership: Actively involved in global collaborations, enhancing the translational impact of his findings.

📊 ACADEMIC CITATIONS AND METRICS

Dr. Huang’s academic metrics underscore his scholarly contributions:

H-Index: Demonstrates significant citation impact in medicinal chemistry and oncology.
Published Articles: Over 50 research papers, including breakthroughs in bioorganic and natural medicinal chemistry.
Research Grants: Secured funding for multiple national and international projects.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

As a visionary in drug discovery, Dr. Huang aspires to expand his research impact by:

Advancing precision medicine approaches tailored to the tumor microenvironment.
Developing next-generation inhibitors targeting stress-response proteins in cancer therapy.
Mentoring the next wave of researchers in innovative medicinal chemistry.

🌏 CONCLUSION

Dr. Shi-liang Huang embodies a blend of academic rigor, research innovation, and educational leadership. His contributions continue to shape the future of medicinal chemistry, with a legacy that inspires collaboration, discovery, and impactful solutions in cancer therapy.

📊🔬NOTABLE PUBLICATION:

A Novel HSF1 Activator Ameliorates Non-Alcoholic Steatohepatitis by Stimulating Mitochondrial Adaptive Oxidation
- Authors: Rao, Y.; Li, C.; Hu, Y.-T.; Ye, J.-M.; Huang, Z.-S.
- Journal: British Journal of Pharmacology
- Year: 2022

Design, Synthesis, and Evaluation of New Sugar-Substituted Imidazole Derivatives as Selective c-MYC Transcription Repressors Targeting the Promoter G-Quadruplex
- Authors: Li, M.-L.; Yuan, J.-M.; Yuan, H.; Chen, S.-B.; Huang, Z.-S.
- Journal: Journal of Medicinal Chemistry
- Year: 2022

Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy
- Authors: Pan, X.; Mao, T.-Y.; Mai, Y.-W.; Huang, Z.-S.; Huang, S.-L.
- Journal: Molecules
- Year: 2022

Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer
- Authors: Jiang, X.-C.; Tu, F.-H.; Wei, L.-Y.; Chen, S.-B.; Huang, Z.-S.
- Journal: Journal of Medicinal Chemistry
- Year: 2022

Design and Synthesis of Bouchardatine Derivatives as a Novel AMP-Activated Protein Kinase Activator for the Treatment of Colorectal Cancer
- Authors: Xu, Y.-H.; Hu, Y.-T.; Xu, S.-M.; Chen, S.-B.; Huang, Z.-S.
- Journal: Journal of Medicinal Chemistry
- Year: 2023

Prof. Linghua Li | Cancer Science | Best Researcher Award

Published on 16/12/202416/12/2024 by Oncology

Prof. Linghua Li | Cancer Science | Best Researcher Award

Guangzhou Eighth People’s Hospital | China

Author Profile

ORCID ID

🌟Linghua Li, Ph.D., M.S., B.S. 🌍

Head Director, Infectious Disease Center
Guangzhou Eighth People’s Hospital, Guangzhou Medical University

👩‍⚕️Biography

Dr. Linghua Li is a distinguished physician and researcher specializing in HIV/AIDS, infectious diseases, and oncology. With over 25 years of clinical experience, she has made significant contributions to understanding and managing infectious diseases, particularly fungal infections and HIV-related complications.

Dr. Li began her academic journey at the Medical School of Peking University, earning a B.S. in Clinical Medicine in 1997. She then pursued advanced studies at Sun Yat-sen University, completing an M.S. in Internal Medicine in 2008 and a Ph.D. in Infectious Diseases in 2011. She further enriched her expertise through visiting scholar positions at UNC-Chapel Hill (2012) and Duke University (2014), focusing on infectious diseases.

As the Head Director of the Infectious Disease Center at Guangzhou Eighth People’s Hospital, Dr. Li oversees clinical trials, patient care, and research initiatives for people living with HIV and at-risk populations. She has been principal investigator (PI) or co-investigator (Co-I) on more than 20 domestic and international research programs. Notable projects include:

National Natural Science Foundation of China (Grant No. 81301480): Investigating the mechanism and function of Phospholipase B in the growth and pathogenicity of P. marneffei.
Guangdong Natural Science Foundation (Grant No. 10151006002000000): Exploring the role of Phospholipase B in P. marneffei invasion of macrophages in AIDS patients.
NIH Fogarty Program: Examining host factors in severe opportunistic complications of AIDS, with a focus on developing targeted prophylactic strategies.

In recent years, Dr. Li has been a Co-PI on groundbreaking HIV PrEP Phase IV clinical trials in Guangzhou, including:

ChiCTR2100048981 and NCT04754139: These studies focus on scaling PrEP access for key populations in China. The trial successfully enrolled 1,007 participants by 2023, with 950 already on PrEP, marking it as the largest trial of its kind in China.

Dr. Li’s work emphasizes translational medicine, data-driven public health strategies, and the implementation of novel interventions like PrEP to curb HIV transmission. Her expertise in site coordination, implementation, data collection, and analysis has been pivotal to these efforts.

🧬Key Areas of Expertise

🔬 HIV Prevention and Treatment
🌿 Opportunistic Infections
📊 Clinical Trials and Data Analysis
🧑‍⚕️ Internal and Infectious Diseases

📚Academic Background

B.S., Clinical Medicine, Medical School of Peking University (1997)
M.S., Internal Medicine, Sun Yat-sen University (2008)
Ph.D., Infectious Diseases, Sun Yat-sen University (2011)
Visiting Scholar, UNC-Chapel Hill (2012)
Visiting Scholar, Duke University (2014)

🔬Research Impact

🌟 Over 20 funded research projects
📄 Numerous publications in infectious disease and public health journals
📚 Active contributor to advancing HIV prevention strategies in China

Dr. Linghua Li remains a leader in the fight against infectious diseases, with a career dedicated to improving global health outcomes. 🌏✨

✨ Conclusion

Dr. Linghua Li’s career exemplifies dedication to advancing the prevention, treatment, and understanding of infectious diseases, particularly HIV/AIDS and associated complications. Through her leadership, innovative research, and clinical expertise, she has significantly impacted global health, especially in developing effective interventions like PrEP for key populations in China. Her contributions to translational medicine and public health continue to pave the way for breakthroughs in managing infectious diseases and improving the lives of those affected worldwide. 🌟🌍

Mr. Toshitaka Hirano | Malignancy | Best Researcher Award

Published on 12/12/202412/12/2024 by Oncology

Mr. Toshitaka Hirano | Malignancy | Best Researcher Award

Pfizer Japan Inc | Japan

AUTHOR PROFILE

ORCID ID

🏫 EARLY ACADEMIC PURSUITS

Mr. Toshitaka Hirano pursued his education in Japan, specializing in fields related to oncology and pharmaceutical sciences. His early academic years were marked by a strong commitment to understanding the mechanisms of malignancy and its risk factors, laying the foundation for his influential career.

💼 PROFESSIONAL ENDEAVORS

Currently associated with Pfizer, Mr. Hirano has established himself as a leading expert in the risk factor analysis of malignancy. His role includes conducting advanced research, collaborating with global teams, and integrating pharmaceutical innovation with clinical practice.

🧬 CONTRIBUTIONS AND RESEARCH FOCUS

Mr. Hirano’s research is focused on identifying malignancy risk factors, particularly in patients with chronic conditions like rheumatoid arthritis. His studies examine the interplay between biological, environmental, and genetic factors contributing to cancer development. He has significantly advanced understanding in areas such as:

Immunogenicity risk associated with biologics
Cardiovascular events in rheumatic disease patients
Safety and effectiveness of novel therapies like tofacitinib

🌏 IMPACT AND INFLUENCE

Mr. Hirano’s work has had a profound impact on both clinical and research landscapes:

Policy and Practice: His findings inform public health guidelines and pharmaceutical strategies.
Patient Outcomes: Through his research, he has contributed to safer and more effective treatments for vulnerable populations.
International Collaboration: His global outreach ensures the dissemination of knowledge and best practices.

📚 ACADEMIC CITES

Mr. Hirano’s scholarly work is widely cited in high-impact journals, demonstrating its relevance and importance. Key publications include articles in International Journal of Rheumatic Diseases, Frontiers in Immunology, and Modern Rheumatology, highlighting his expertise in malignancy risk within rheumatic populations.

🏆 LEGACY AND FUTURE CONTRIBUTIONS ON MALIGNANCY

As a trailblazer in the field, Mr. Hirano is building a legacy of innovation and dedication to improving cancer outcomes. His future efforts aim to:

Develop predictive models for malignancy risks.
Enhance personalized medicine approaches.
Mentor the next generation of researchers in oncology and pharmaceutical sciences.

📌 OTHER IMPORTANT TOPICS

🔍 INTERDISCIPLINARY INTEGRATION

Mr. Hirano’s work bridges multiple fields, including oncology, immunology, and rheumatology, showcasing the value of a holistic research approach.

🌟 MENTORSHIP AND TEAM LEADERSHIP

He plays an active role in guiding young researchers and fostering collaborative environments that drive innovation.

🔔 PATIENT-CENTERED FOCUS

By emphasizing real-world data and patient-centered outcomes, Mr. Hirano ensures his work directly benefits those in need.

✨ CONCLUSION

Mr. Toshitaka Hirano’s dedication to malignancy risk analysis exemplifies the power of focused research to drive meaningful change. His work at Pfizer and beyond demonstrates a commitment to innovation, collaboration, and improving global health. With a legacy rooted in impactful research and a vision for a healthier future, Mr. Hirano continues to inspire and lead in the fight against cancer.

📊🔬NOTABLE PUBLICATION:

1️⃣ Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real-World Setting in Japan
- Authors: Kunihiro Yamaoka, Sugiyama N, Hoshi M, Jo JY, Kichul Shin, Hirano T
- Journal: International Journal of Rheumatic Diseases
- Year: 2024
2️⃣ Individual and Population-Level Variability in HLA-DR Associated Immunogenicity Risk of Biologics Used for the Treatment of Rheumatoid Arthritis
- Authors: Sugiyama N, Terry FE, Gutierrez AH, Hirano T, Hoshi M, Mizuno Y, Martin W, Yasunaga S, Niiro H, Fujio K, et al.
- Journal: Frontiers in Immunology
- Year: 2024
3️⃣ Six-Month Safety and Effectiveness of Tofacitinib in Patients With Rheumatoid Arthritis in Japan: Interim Analysis of Post-Marketing Surveillance
- Authors: Masataka Kuwana, Sugiyama N, Momohara S, Atsumi T, Takei S, Naoto Tamura, Masayoshi Harigai, Fujii T, Matsuno H, Takeuchi T, et al.
- Journal: Modern Rheumatology
- Year: 2024

Prof. Long Yang | Immunology | Best Researcher Award

Published on 11/12/202411/12/2024 by Oncology

Prof. Long Yang | Immunology | Best Researcher Award

Tianjin University of Traditional Chinese Medicine | China

AUTHOR PROFILE

Scopus

ORCID ID

LONG YANG, MD & PhD

🎓 EDUCATION

Doctor of Philosophy (PhD), Division of Experimental Medicine, Faculty of Medicine, McGill University, Canada (2005–2009)
Master of Medicine, Division of Pathology and Pathophysiology, Dalian Medical University, China (2000–2003)
Bachelor of Medicine (MD), Division of Clinical Medicine, Dalian Medical University, China (1989–1994)

🏢 EARLY ACADEMIC PURSUITS

Long Yang embarked on a robust academic journey with a foundational education in clinical medicine, followed by a specialization in pathology and pathophysiology. His PhD from McGill University further honed his expertise in experimental medicine, marking the start of an illustrious research career.

💼 PROFESSIONAL ENDEAVORS

Professor (2021–Present)
Institute of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, China.
Focused on advancing integrative medicine through innovative research and teaching.
Research Associate (2018–2020)
Lady Davis Institute, Jewish General Hospital, McGill University, Canada.
Contributed to cutting-edge research in cellular and molecular medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Yang’s research interests lie at the intersection of integrative medicine and experimental cellular mechanisms. He has contributed significantly to understanding infectious diseases and cellular pathophysiology. His work bridges traditional Chinese medicine and contemporary medical research, fostering novel therapeutic strategies.

🌟 IMPACT AND INFLUENCE

Dr. Yang’s tenure in academia and research institutions has been marked by:

Publication of numerous peer-reviewed articles in high-impact journals.
Development of interdisciplinary approaches combining traditional medicine and modern science.
Recognition as a thought leader in cellular and infection microbiology.

📚 ACADEMIC CITATIONS

His research has earned widespread recognition, with citations underscoring the global relevance of his contributions to experimental medicine and integrative healthcare solutions.

🔗 PROFESSIONAL SERVICE

Associate Editor, Frontiers in Cellular and Infection Microbiology.
Played a pivotal role in curating impactful content, ensuring scientific rigor, and promoting advancements in the field.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Long Yang’s work continues to shape the integration of traditional and modern medical paradigms. His dedication to mentoring emerging scholars and contributing to healthcare innovations ensures a lasting legacy in both academia and clinical applications.

🌟CONCLUSION 🌿

Dr. Long Yang’s distinguished career as a researcher, educator, and practitioner showcases his unwavering dedication to advancing medicine through innovation and collaboration. By integrating traditional Chinese medicine with modern scientific methodologies, he has made a profound impact on healthcare, bridging cultural and academic divides.

📊🔬NOTABLE PUBLICATION:

The Gamble Between Oncolytic Virus Therapy and IFN
- Authors: Li, Q., Tan, F., Wang, Y., Yang, L., Cen, S.
- Journal: Frontiers in Immunology
- Year: 2022

Repurposing of HIV/HCV Protease Inhibitors Against SARS-CoV-2 3CLpro
- Authors: Ma, L., Li, Q., Xie, Y., Yang, L., Cen, S.
- Journal: Antiviral Research
- Year: 2022

SERINC5 Restricts Influenza Virus Infectivity
- Authors: Zhao, F., Xu, F., Liu, X., Liang, C., Guo, F.
- Journal: PLoS Pathogens
- Year: 2022

COVID-19 Pandemic: A Multidisciplinary Perspective on the Pathogenesis of a Novel Coronavirus from Infection, Immunity and Pathological Responses
- Authors: Yi, J., Miao, J., Zuo, Q., Kong, X., Yang, L.
- Journal: Frontiers in Immunology
- Year: 2022

Interferon-Inducible SAMHD1 Restricts Viral Replication Through Downregulation of Lipid Synthesis
- Authors: An, N., Ge, Q., Shao, H., Yang, L., Cen, S.
- Journal: Frontiers in Immunology
- Year: 2022

Prof. Jian Zaiyou | Botanical Drug | Best Researcher Award

Published on 10/12/202410/12/2024 by Oncology

Prof. Jian Zaiyou | Botanical Drug | Best Researcher Award

Henan Institute of Science and Technology | China

AUTHOR PROFILE

Scopus

🎓EARLY ACADEMIC PURSUITS 🌱

Born in January 1973 in Huai Bin County, Henan Province, China, you began your academic journey with a keen interest in traditional Chinese medicine. Your pursuit of excellence led you to Beijing University of Chinese Medicine, where you obtained your Ph.D. in 2010. This foundational education equipped you with deep knowledge and expertise in medicinal botany and Chinese medicine, shaping your future academic and professional endeavors.

🏫PROFESSIONAL ENDEAVORS 🌿

Currently, you serve as an Associate Professor at the Henan Institute of Science and Technology, where you teach key subjects such as Chinese Medicine Processing, Chinese Medicine, and Medicinal Botany. Your teaching is enriched by practical applications and extensive research experience, fostering a deeper understanding of traditional Chinese medicinal practices among students.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON BOTANICAL DRUG📚

Your research centers on the cultivation of medicinal plants, quality evaluation of Chinese medicine, and related fields. You have successfully presided over two research projects funded by the Science and Technology Department of Henan Province, which have significantly advanced the regional understanding of medicinal botany. Additionally, your contributions include authoring influential books such as:

Chinese Authentic Medicine
Wolfberry Practical Production Technology
Botany

Your work has provided practical and theoretical frameworks for improving the cultivation and processing of medicinal plants.

📖IMPACT AND INFLUENCE 🌟

With over 20 published scientific papers and 2 invention patents, your scholarly impact extends beyond Henan Province, influencing Chinese medicine practices at both regional and national levels. Your patents demonstrate innovation in the field, highlighting your commitment to improving traditional medicine through modern techniques.

📈ACADEMIC CITES 📝

Your contributions to Chinese medicine and botany have garnered attention in academic circles, with your work frequently cited in journals focused on medicinal botany, traditional medicine quality evaluation, and innovative cultivation techniques. These citations underline the importance of your research in advancing the field.

🚀LEGACY AND FUTURE CONTRIBUTIONS🌍

Your legacy lies in bridging traditional Chinese medicine with modern scientific approaches. By educating future generations and enhancing the quality standards of Chinese medicine, you have created a sustainable foundation for innovation in this field. Future contributions could include exploring global collaborations to integrate traditional Chinese medicine into international therapeutic practices and advancing the commercialization of medicinal botany technologies.

📚HIGHLIGHT 🌟

Through your dedicated teaching, pioneering research, and impactful publications, you have established yourself as a leading figure in the realm of Chinese medicine and medicinal botany. Your work not only preserves the rich traditions of Chinese medicine but also propels it into the future, ensuring its relevance in modern science and healthcare.

🌟CONCLUSION 🌿

Your journey from Huai Bin County to becoming an esteemed Associate Professor and researcher exemplifies dedication to advancing traditional Chinese medicine and medicinal botany. Through impactful teaching, innovative research, and valuable publications, you have significantly contributed to the preservation and modernization of Chinese medicinal practices. Your work has laid a robust foundation for future advancements, ensuring that the rich heritage of Chinese medicine continues to thrive in an evolving global healthcare landscape. As you expand your contributions, your influence will undoubtedly inspire new generations of scholars and practitioners, fostering a lasting legacy in the field.

📊🔬NOTABLE PUBLICATION:

Photosynthetic and Chlorophyll Fluorescence Characteristics of Isodon rubescens (Hemsley) H. Hara
- Authors: Zaiyou, J.; Xiuren, Z.; Jing, T.
- Journal: Scientific Reports
- Year: 2020

Evaluate the Photosynthesis and Chlorophyll Fluorescence of Epimedium brevicornu Maxim
- Authors: Zaiyou, J.; Xiaomin, T.; Hongsheng, W.; Guifang, X.
- Journal: Scientific Reports
- Year: 2022

Study on the Cause of Peeling and Withering in Isodon rubescens Stems in Winter
- Authors: Zaiyou, J.; Xiaomin, T.; Lei, D.
- Journal: Journal of King Saud University – Science
- Year: 2022

Analysis on the Quality of Epimedii folium Originating from Cultivated Epimedium pubescens Maxim
- Authors: Zaiyou, J.; Guifang, X.; Jing, T.
- Journal: Bangladesh Journal of Botany
- Year: 2021

Photosynthesis Capacity and Chlorophyll Fluorescence Characteristics of the Isodon rubescens (Hemsley) H. Hara Stem
- Authors: Zaiyou, J.I.A.N.; Susu, J.I.A.N.; Xiaomin, T.A.N.G.; Genhai, H.U.
- Journal: Scientific Reports
- Year: 2024

The Affiliated Hospital of Jiaxing University | China

🏫 EARLY ACADEMIC PURSUITS

💼 PROFESSIONAL ENDEAVORS

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON THORACIC NEOPLASMS

🌟 IMPACT AND INFLUENCE

📊 ACADEMIC CITATIONS

🏅 LEGACY AND FUTURE CONTRIBUTIONS

OTHER IMPORTANT TOPICS

🌐 COMMUNITY ENGAGEMENT

📚 CONTINUOUS LEARNING

🧬 INNOVATIVE PRACTICES

📝 CONCLUSION

National Institute of Metrology | China

🌟 Biography of Huang Ji 🌟

🧪 Full Name:

🏛️ Designation:

🏢 Institution/Organization:

🌐 Academic and Professional Background

🔬 Research and Innovations

🤝 Collaborations

🌟 Professional Memberships

🔍 Areas of Research

🚀 Key Contributions

Beijing Friendship Hospital, Capital Medical University | China

Biography of Xin Yan Zhao, M.D., Ph.D. 🌟🩺

🎓 Education

👩‍⚕️ Professional Experience

🏆 Awards and Honors

🌐 Roles in Professional Societies

🌏 CONCLUSION

Jiangsu University | China

🌍 Dr. Ohidul Alam: Postdoctoral Research Fellow and Environmental Innovator 🌱

💧Current Position

♻️Research Focus

🎓Education

🛠Career Snapshot

🖋Publications and Contributions

🏆Recognition and Awards

🤝Professional Memberships

🧾Reviewer Roles

📚Training and Skills Development

🌏 CONCLUSION

Air Force Medical University | China

🌟Biography of Dehua, Li 🦷🧬

🔬 Research Focus

💡 Key Contributions

🔧 Core Skills

🏆 Awards and Grants

🌏 CONCLUSION

Sun Yat-sen University | China

🧑‍🔬 DR. SHI-LIANG HUANG

🎯 OBJECTIVE

📘 EARLY ACADEMIC PURSUITS

🏢 PROFESSIONAL ENDEAVORS

🧪 CONTRIBUTIONS AND RESEARCH FOCUS

🌟 IMPACT AND INFLUENCE

📊 ACADEMIC CITATIONS AND METRICS

🏆 LEGACY AND FUTURE CONTRIBUTIONS

🌏 CONCLUSION

Guangzhou Eighth People’s Hospital | China

🌟Linghua Li, Ph.D., M.S., B.S. 🌍

👩‍⚕️Biography

🧬Key Areas of Expertise

📚Academic Background

🔬Research Impact

✨ Conclusion

Pfizer Japan Inc | Japan

🏫 EARLY ACADEMIC PURSUITS

💼 PROFESSIONAL ENDEAVORS

🧬 CONTRIBUTIONS AND RESEARCH FOCUS

🌏 IMPACT AND INFLUENCE

📚 ACADEMIC CITES

🏆 LEGACY AND FUTURE CONTRIBUTIONS ON MALIGNANCY

📌 OTHER IMPORTANT TOPICS

🔍 INTERDISCIPLINARY INTEGRATION

🌟 MENTORSHIP AND TEAM LEADERSHIP

🔔 PATIENT-CENTERED FOCUS

✨ CONCLUSION

Tianjin University of Traditional Chinese Medicine | China

LONG YANG, MD & PhD